Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
reports
Arecor Therapeutics PLC (AREC) Stock Price & Analysis
0 Followers
AREC Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range200.00p - 435.00p
Previous Close250p
Volume2.95K
Average Volume (3M)14.18K
Market Cap
94.25M
Enterprise Value6.30B
Total Cash (Recent Filing)£13.72M
Total Debt (Recent Filing)£169.00K
Price to Earnings (P/E)-10.3
Beta-0.14
Next Earnings
Apr 20, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume14,180
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AREC FAQ
What was Arecor Therapeutics PLC’s price range in the past 12 months?
Arecor Therapeutics PLC lowest stock price was 200.00p and its highest was 435.00p in the past 12 months.
What is Arecor Therapeutics PLC’s market cap?
Currently, no data Available
When is Arecor Therapeutics PLC’s upcoming earnings report date?
Arecor Therapeutics PLC’s upcoming earnings report date is Apr 20, 2023 which is in 23 days.
How were Arecor Therapeutics PLC’s earnings last quarter?
Arecor Therapeutics PLC released its earnings results on Sep 08, 2022. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is Arecor Therapeutics PLC overvalued?
According to Wall Street analysts Arecor Therapeutics PLC’s price is currently Overvalued.
Does Arecor Therapeutics PLC pay dividends?
Arecor Therapeutics PLC does not currently pay dividends.
What is Arecor Therapeutics PLC’s EPS estimate?
Arecor Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arecor Therapeutics PLC have?
Arecor Therapeutics PLC has 30,618,183 shares outstanding.
What happened to Arecor Therapeutics PLC’s price movement after its last earnings report?
Arecor Therapeutics PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Arecor Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:AREC
---
Arecor Therapeutics PLC Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.89%
12-Months-Change
Fundamentals
Return on Equity
-41.47%
Trailing 12-Months
Asset Growth
-26.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arecor Therapeutics PLC
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Arestat, it is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.
---
F-star Therapeutics
―
Mereo Biopharma Group Plc
―
Vaccitech Plc
―
4basebio UK Societas
―
Achilles Therapeutics
―
---